Dr. Toresa Martell, D.O. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 2085 Thompson Rd, Coos Bay, OR 97420 Phone: 541-269-5333 |
Mr. James Paul Kowall, M.D. Psychiatry & Neurology - Neurology Medicare: Not Enrolled in Medicare Practice Location: 1925 Thompson Rd, Coos Bay, OR 97420 Phone: 541-267-0330 Fax: 541-267-0265 |
Dr. Jeanine Shannon-allison Collier, M.D. Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 281 Laclair St, Coos Bay, OR 97420 Phone: 541-266-6700 Fax: 541-888-8726 |
Alfredo J Velez, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 150 S Wall St, Coos Bay, OR 97420 Phone: 541-435-7200 |
Miss Linda L Bufton, M.D. Psychiatry & Neurology - Neurology Medicare: Not Enrolled in Medicare Practice Location: 1900 Woodland Drive, Coos Bay, OR 97420 Phone: 541-267-5151 Fax: 541-266-4553 |
Dr. Charles P Reagan, MD Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 1865 Thompson Road, Coos Bay, OR 97420 Phone: 541-267-7757 Fax: 541-267-6688 |
Dr. Anton Erikovich Lotman, M.D. Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 1900 Woodland Drive, Coos Bay, OR 97420 Phone: 541-267-5151 Fax: 541-266-4553 |
News Archive
Scheduled for October 17-20, 2010 at the Westfields Marriott near Dulles International Airport, Washington, DC, the symposium will be a premier event for scientists, clinicians and others interested in current and future applications of MR-guided focused ultrasound. The program will offer a multifaceted exploration of this emerging field and feature plenary sessions, panel discussions, poster presentations and technical exhibits.
How the government calculates insurance subsidies makes the cheapest bronze plans more costly for young people relative to those aged 54 to 64, reports The Philadelphia Inquirer. Meanwhile, Oregon budgets $2 million for a lawsuit fight with Oracle over its health insurance marketplace.
Abbott (NYSE: ABT) today announced it has completed enrollment of three clinical trials to support approvals of the company's revolutionary Absorbâ„¢ Bioresorbable Vascular Scaffold (BVS) in the United States, Japan and China.
Boston University (BU) on Monday launched a five-year, $10 million global health initiative that aims to "bolster research and education" and "build a nationwide consortium of universities devoted to improving health in the Third World," the Boston Globe reports.
A team of 18 researchers at Moffitt Cancer Center in Tampa, Fla., have found that treating high-risk, soft tissue sarcoma patients with a combination of implanted dendritic cells (immune system cells) and fractionated external beam radiation (EBRT) provided more than 50 percent of their trial patients with tumor-specific immune responses lasting from 11 to 42 weeks.
› Verified 1 days ago